Events Partner Content 3rd Annual Medical Device Project and Portfolio Management This two-day event guarantees top notch networking
News Aimmune to file peanut allergy treatment by year-end Backed by a $202 million fundraiser, biotech Aimmune has announced plans to file its potential peanut allergy treatment at the end of the year following a phase 3 trial success.
Events Partner Content BioData World West Returns to San Francisco March 13-14 Harnessing the power of big data in precision medicine.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
